Invivyd (IVVD) EPS (Diluted) Growth (3y) (2024 - 2025)
Invivyd (IVVD) EPS (Diluted) Growth (3y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 37.28% |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Invivyd | 105.05 Mn | -121.64 Mn | 16.07 Mn | 45.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.83% |
| Sep 30, 2025 | 47.93% |
| Jun 30, 2025 | 38.14% |
| Mar 31, 2025 | 48.28% |
| Dec 31, 2024 | 56.92% |
| Sep 30, 2024 | 18.92% |
| Jun 30, 2024 | 86.75% |